Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Elevated Level of Prostate Specific Antigen Among Prostate Cancer Patients and High Prevalence in the Gangetic Zone of Bihar, India

  • Nath, A. (Research Centre, Mahavir Cancer Sansthan) ;
  • Singh, J.K. (Research Centre, Mahavir Cancer Sansthan) ;
  • Vendan, S. Ezhil (Research Centre, Mahavir Cancer Sansthan) ;
  • Priyanka, Priyanka (Research Centre, Mahavir Cancer Sansthan) ;
  • Sinha, Shreya (Research Centre, Mahavir Cancer Sansthan)
  • Published : 2012.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Prostate cancer (CaP) is a common reproductive cancer among men. This study was conducted to correlate the cancer incidence with Gangetic zone and to correlate the tumor marker prostate specific antigen (PSA) level in serum with different age groups and stage of malignancy. Patients suffering from CaP in the pathology unit of Mahavir Cancer Sansthan (Hospital and Research Centre), Patna, Bihar, India were studied from June 2009 to May 2010. PSA level in the serum of CaP patients was estimated by ELISA method. CaP incidence was highly recorded in Gangetic zone than the non-Gangetic zone. Maximum patients were in the 56 - 75 years age group with a marked predominance. Results of PSA examination showed that serum PSA level was not correlating with the age of patient and stage of malignancy. Significantly, elevated level of more than 10 ng/ml of PSA was recorded among the studied cancer patients. In this study, it is concluded that Gangetic zone habitat have high risk of CaP and elevated level of PSA was marked in Bihar, India.

Keywords

References

  1. Chatterjee A, Chatterji U (2010). Arsenic abrogates the estrogensignalling pathway in the rat uterus. Reprod Biol Endocrin, 8, 1-11 https://doi.org/10.1186/1477-7827-8-1
  2. Christensen TL, Andriole GL (2009). Prostatic hyperplasia: current treatment strategies consultant 49(2). February 2009. http;//www.consultantive.com/display/article/10162/13766744.Retr.
  3. Dennis LK, Lynch CF, Lorner JC (2000). Epidemiologic association between prostatitis and prostate cancer. Urology, 60, 78-83
  4. Diamanti-Kandarakis E, Bourguignon J, Giudice LC, et al (2009). Endocrine-disturbing chemicals. Endocrin Rev, 30, 293-342. https://doi.org/10.1210/er.2009-0002
  5. Ezeiruaku FC, Eze EM, Ukaji DC, Okoye FC (2011). Prevalance of prostate cancer among men with elevated prostate specific antigen level in Ikwerre local government area of river state, Nigeria. JETEAS, 2, 335-7
  6. Modugno F, Weissfeld JL, Trump DL, et al (2001). Allelic variants of aromatase and nitrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res, 7, 3092-6
  7. Nandakumar A (1996). National cancer registry programme, Indian Council of Medical Research, Consolidated report of the population based cancer registries, New Delhi, India: 1990-1996.
  8. Saha D (2009). Arsenic groundwater contamination in parts of middle Ganga plain, Bihar. Curr Sci, 97, 753-5.

Cited by

  1. Plasma Vascular Endothelial Growth Factors A and C in Patients undergoing Prostatic Biopsy and TURP for Suspected Prostatic Neoplasia vol.14, pp.3, 2013, https://doi.org/10.7314/APJCP.2013.14.3.2053
  2. Utility of Digital Rectal Examination, Serum Prostate Specific Antigen, and Transrectal Ultrasound in the Detection of Prostate Cancer: A Developing Country Perspective vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.3087
  3. Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia vol.15, pp.1, 2015, https://doi.org/10.1186/s12894-015-0110-x